NCT03143205View on ClinicalTrials.gov

Gene Expression Outcomes in Interventions for Substance Using HIV+ Minority Men

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

December 1, 2018

Study Completion Date

March 8, 2019

Conditions
Human Immunodeficiency Virus InfectionInflammation
Interventions
BEHAVIORAL

AWARENESS for Sexual Minorities

9 session, individually delivered, cognitive behavioral intervention focused on modifying sexual minority stress responses to reduce the impact of sexual minority stress experiences.

BEHAVIORAL

Writing tasks

Writing sessions to explore daily activities.

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of California, San Francisco

OTHER

NCT03143205 - Gene Expression Outcomes in Interventions for Substance Using HIV+ Minority Men | Biotech Hunter | Biotech Hunter